TET3
TET3 (tet methylcytosine dioxygenase 3) is a dioxygenase that oxidises 5-methylcytosine in genomic DNA, the first step towards cytosine demethylation. It was formerly named tet oncogene family member 3 and is also known as MGC22014 and hCG_40738. Browse Assay Genie's current range of TET3 research reagents below, or read on for the biology behind the target.
TET3 catalyses the conversion of the modified genomic base 5-methylcytosine (5mC) into 5-hydroxymethylcytosine (5hmC). It then mediates the further conversion of 5hmC into 5-formylcytosine (5fC) and of 5fC into 5-carboxylcytosine (5caC). This series of oxidations probably constitutes the first step in cytosine demethylation. TET3 plays a key role in epigenetic chromatin reprogramming in the zygote after fertilisation. DNA demethylation occurs selectively in the paternal pronucleus before the first cell division, and TET3 drives it there. The adjacent maternal pronucleus and certain paternally imprinted loci are protected. On maternal chromatin, DPPA3/PGC7 prevents TET3 from binding.
The TET3 protein binds selectively to the promoter regions of target genes and helps regulate the expression of numerous developmental genes. It binds preferentially to DNA containing CpG dinucleotides rather than CpH, and to hemimethylated CpG and hemimethylated hydroxymethyl-CpG. Beyond demethylation, TET3 helps recruit the O-GlcNAc transferase OGT to CpG-rich transcription start sites of active genes, which promotes histone H2B GlcNAcylation by OGT. NCBI Gene annotates the protein with RNA polymerase II cis-regulatory region sequence-specific DNA binding, methyl-CpG binding and zinc ion binding activities. It is also linked to positive regulation of transcription by RNA polymerase II and to protein O-linked glycosylation. Localisation is annotated to the nucleus, cytoplasm and chromosome, and the protein is predicted to be present in the male pronucleus.
The TET3 gene belongs to the TET family, alongside TET1 and TET2, and HGNC places it in the CXXC-type zinc finger and Tet methylcytosine dioxygenase gene groups. The former name, tet oncogene family member 3, reflects the family's early history. TET3 is reported as a biomarker of oesophageal squamous cell carcinoma. The mouse ortholog is Tet3.
TET3 oxidises 5mC to 5hmC, 5fC and 5caC, the probable first step in cytosine demethylation, making it central to studies of DNA modification.
TET3 drives selective demethylation of the paternal pronucleus in the zygote, while DPPA3/PGC7 blocks its binding on maternal chromatin.
TET3 binds promoter regions of target genes and contributes to the regulation of numerous developmental genes.
NCBI Gene reports TET3 as a biomarker of oesophageal squamous cell carcinoma, giving a starting point for disease-focused work.
TET3 is a dioxygenase that converts 5-methylcytosine into 5-hydroxymethylcytosine, then 5-formylcytosine and 5-carboxylcytosine, probably the first step in cytosine demethylation. It also helps recruit OGT to CpG-rich transcription start sites of active genes, promoting histone H2B GlcNAcylation.
The HGNC name is tet methylcytosine dioxygenase 3, and the UniProt name is methylcytosine dioxygenase TET3. The previous name was tet oncogene family member 3. Aliases include MGC22014 and hCG_40738. Use these terms when searching the literature, as older records may use them.
The mouse ortholog is Tet3, and TET3 belongs to the TET family with TET1 and TET2. NCBI Gene lists TET3 as a biomarker of oesophageal squamous cell carcinoma. Check the datasheet of any product for its validated reactivity.
Other TET family dioxygenases that act on methylcytosine in DNA demethylation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt O43151; product specifications from Assay Genie datasheets.